Best in 7 days Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell US$ 25.60 Sold : Login>>
Best in 7 days Class II senolytics inhibit survival pathways elicited by senescent US$ 24.52 Sold : Login>>
Best in 7 days The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 23.72 Sold : Login>>
BPC-157: The peptide with big claims and scant evidence US$ 25.87 Min. order: 1 piece ★★★★★ 4.3 (266 reviews) Sold : Login>>
FDA's Overreach on Compounded Peptides US$ 28.90 Min. order: 1 piece ★★★★★ 4.3 (136 reviews) Sold : Login>>
Early evidence suggests BPC-157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio US$ 29.03 Min. order: 1 piece ★★★★★ 4.6 (146 reviews) Sold : Login>>
FDA mulls compounding for peptides previously flagged over safety risks US$ 26.77 Min. order: 1 piece ★★★★★ 4.4 (215 reviews) Sold : Login>>
The FDA just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step US$ 28.31 Min. order: 1 piece ★★★★★ 5.0 (166 reviews) Sold : Login>>